Covid: France schools to close under third lockdown

Meanwhile, experts investigating possible links between the Oxford-AstraZeneca vaccine and blood clots have so far found no specific risk factors, such as age, gender or medical history, European Union regulators have said. The European Medicines Agency (EMA), however, said that analysis was continuing.